SN
VRTX icon

Sittner & Nelson’s Vertex Pharmaceuticals VRTX Stock Holding History

Sittner & Nelson’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Hold
615
– – 0.1% 137
2026
Q1 		$275K Hold
615
– – 0.1% 139
2025
Q4 		$294K Hold
615
– – 0.1% 126
2025
Q3 		$241K Hold
615
– – 0.09% 133
2025
Q2 		$274K Buy
615
+17
+3% +$7.83K 0.11% 120
2025
Q1 		$290K Hold
598
– – 0.12% 114
2024
Q4 		$241K Hold
598
– – 0.1% 113
2024
Q3 		$278K Hold
598
– – 0.12% 110
2024
Q2 		$280K Hold
598
– – 0.14% 91
2024
Q1 		$250K Hold
598
– – 0.13% 104
2023
Q4 		$243K Buy
598
+300
+101% +$111K 0.13% 100
2023
Q3 		$104K Buy
298
+60
+25% +$21K 0.06% 148
2023
Q2 		$83.8K Hold
238
– – 0.05% 160
2023
Q1 		$75K Buy
238
+113
+90% +$33.9K 0.04% 181
2022
Q4 		$36.1K Hold
125
– – 0.02% 242
2022
Q3 		$36K Sell
125
-59
-32% -$17K 0.02% 236
2022
Q2 		$52K Buy
184
+59
+47% +$15.8K 0.03% 211
2022
Q1 		$33K Buy
125
+50
+67% +$11.9K 0.02% 234
2021
Q4 		$16K Sell
75
-25
-25% -$4.86K 0.01% 295
2021
Q3 		$18K Hold
100
– – 0.01% 267
2021
Q2 		$20K Buy
+100
New +$20.9K 0.01% 245

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sittner & Nelson's VRTX Position: Q2 2026 in Review

Sittner & Nelson held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 615 shares worth $305K. The position accounts for 0.1% of the portfolio, ranked #137.

Sittner & Nelson first reported a position in VRTX in Q2 2021 and has held it in 21 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Sittner & Nelson held 615 shares of Vertex Pharmaceuticals worth $305K as of Q2 2026.
  • Sittner & Nelson left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.1% of Sittner & Nelson's portfolio in Q2 2026, its #137 holding.
  • Sittner & Nelson first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Sittner & Nelson's 13F filing for Q2 2026, filed 7 Aug 2026.